BioSpace News Archive

Business

Solid Biosciences Provides Third Quarter 2021 Business Update and Financial Results

Solid Biosciences Inc. today provided a business update as well as financial results for the third quarter ended September 30, 2021.

November 3, 2021
·
10 min read
BioMidwest

Zimmer Biomet to Present at Stifel’s 2021 Virtual Healthcare Conference

Zimmer Biomet Holdings, Inc. today announced that Chairman, President and CEO Bryan Hanson and Executive Vice President and CFO Suky Upadhyay will be presenting at Stifel’s 2021 Virtual Healthcare Conference on Wednesday, November 17, 2021 , at 10:40 a.m. Eastern Time .

November 3, 2021
·
1 min read
BioMidwest

Centene Sells Majority Stake In U.S. Medical Management

Centene Corporation announced that it has signed a definitive agreement to sell a majority stake in U.S. Medical Management, LLC to Rubicon Founders; Valtruis, a WCAS company; Oak HC/FT; and HLM Venture Partners.

November 3, 2021
·
10 min read
Business

Karyopharm Reports Strong Third Quarter 2021 Financial Results and Provides Business Highlights

Karyopharm Therapeutics Inc. today reported financial results for the quarter ended September 30, 2021 and provided business highlights.

November 3, 2021
·
22 min read
Business

Spectrum Pharmaceuticals to Report Third Quarter 2021 Financial Results and Provide Corporate Update

Spectrum Pharmaceuticals today announced it will host a conference call to discuss the third quarter 2021 financial results and provide a corporate update on Wednesday, November 10, 2021 at 4:30 p.m. Eastern/1:30 p.m. Pacific.

November 3, 2021
·
3 min read
Prilenia Closes Oversubscribed $43 Million in Series B Financing Round

Prilenia Therapeutics B.V. today announced that it has raised $43M in an oversubscribed Series B financing round.

November 3, 2021
·
5 min read
Business

Taysha Gene Therapies to Release Third Quarter 2021 Financial Results and Host Conference Call and Webcast on November 10

Taysha Gene Therapies, Inc. today announced that it will report its financial results for the third quarter ended September 30, 2021, and host a corporate update conference call on November 10

November 3, 2021
·
1 min read
FDA

AVROBIO Receives Rare Pediatric Disease Designation from the U.S. FDA for AVR-RD-05, a Gene Therapy for Mucopolysaccharidosis Type II (MPSII) or Hunter Syndrome

AVROBIO, Inc today announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease Designation to AVR-RD-05, its lentiviral gene therapy for the treatment of mucopolysaccharidosis type II (MPSII), or Hunter syndrome

November 3, 2021
·
7 min read
Business

Rocket Pharmaceuticals Reports Third Quarter 2021 Financial Results and Highlights Recent Progress

Rocket Pharmaceuticals, Inc. today reports financial results for the quarter ending September 30, 2021 and updates on the Company’s key pipeline developments, business operations, and upcoming milestones.

November 3, 2021
·
12 min read
InflaRx to Present at the Credit Suisse 30th Annual Healthcare Conference

InflaRx announced today that Prof. Niels C. Riedemann, Chief Executive Officer and Founder of InflaRx, will present a corporate overview during a fireside chat at the Credit Suisse 30th Annual Healthcare Conference.

November 3, 2021
·
3 min read